These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31349010)

  • 1. Aspirin desensitization or biologics for AERD?
    Steinke JW
    Ann Allergy Asthma Immunol; 2019 Oct; 123(4):333-334. PubMed ID: 31349010
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.
    Sweis AM; Locke TB; Ig-Izevbekhai KI; Lin TC; Kumar A; Douglas JE; Corr AM; Civantos AM; Tripathi SH; Kennedy DW; Kohanski MA; Palmer JN; Adappa ND; Bosso JV
    Allergy Asthma Proc; 2021 Mar; 42(2):136-141. PubMed ID: 33685558
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
    Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
    Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.
    Pelletier T; Roizen G; Ren Z; Hudes G; Rosenstreich D; Jerschow E
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1319-1321. PubMed ID: 30144584
    [No Abstract]   [Full Text] [Related]  

  • 5. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
    DeGregorio GA; Singer J; Cahill KN; Laidlaw T
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of aspirin desensitization practices among allergists and fellows in training in the United States.
    Waldram JD; White AA
    J Allergy Clin Immunol Pract; 2016; 4(6):1253-1255. PubMed ID: 27452889
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin desensitization vs biologics for patients with aspirin-exacerbated respiratory disease.
    Laidlaw TM
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):118-119. PubMed ID: 32771353
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin desensitization in aspirin-exacerbated respiratory disease: New insights into the molecular mechanisms.
    Bobolea I; Del Pozo V; Sanz V; Cabañas R; Fiandor A; Alfonso-Carrillo C; Salcedo MÁ; Heredia Revuelto R; Quirce S
    Respir Med; 2018 Oct; 143():39-41. PubMed ID: 30261990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.
    Stevens WW; Jerschow E; Baptist AP; Borish L; Bosso JV; Buchheit KM; Cahill KN; Campo P; Cho SH; Keswani A; Levy JM; Nanda A; Laidlaw TM; White AA
    J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data.
    San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case.
    Mahdavinia M; Batra PS; Codispoti C
    Ann Allergy Asthma Immunol; 2019 Sep; 123(3):311-312. PubMed ID: 31247304
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to desensitization in aspirin-exacerbated respiratory disease.
    Scott DR; White AA
    Ann Allergy Asthma Immunol; 2014 Jan; 112(1):13-7. PubMed ID: 24331387
    [No Abstract]   [Full Text] [Related]  

  • 14. In reply: Aspirin desensitization for aspirin-exacerbated respiratory disease in the era of biologics: Clinical perspective.
    Levy JM; Kuruvilla M
    Int Forum Allergy Rhinol; 2021 Apr; 11(4):824-825. PubMed ID: 33063465
    [No Abstract]   [Full Text] [Related]  

  • 15. Omalizumab can inhibit respiratory reaction during aspirin desensitization.
    Lang DM; Aronica MA; Maierson ES; Wang XF; Vasas DC; Hazen SL
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):98-104. PubMed ID: 29777744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin desensitization for aspirin-exacerbated respiratory disease in the era of biologics: Clinical perspective.
    Bosso JV
    Int Forum Allergy Rhinol; 2021 Apr; 11(4):822-823. PubMed ID: 33070455
    [No Abstract]   [Full Text] [Related]  

  • 17. AERD Associated Nasal Polyposis: Efficacy of Postoperative Antileukotriene Therapy in Comparison with Aspirin Desensitization. A Retrospective Study.
    San Nicoló M; Habermann N; Havel M
    Int Arch Allergy Immunol; 2020; 181(10):790-798. PubMed ID: 32777782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based approach to aspirin desensitization in aspirin-exacerbated respiratory disease.
    Woessner KM; White AA
    J Allergy Clin Immunol; 2014 Jan; 133(1):286-7.e1-9. PubMed ID: 24369807
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
    Świerczyńska-Krępa M; Sanak M; Bochenek G; Stręk P; Ćmiel A; Gielicz A; Plutecka H; Szczeklik A; Niżankowska-Mogilnicka E
    J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of aspirin exacerbated respiratory disease patients treated with aspirin desensitization and biologics.
    D'Souza GE; Nwagu U; Barton B; Unsal AA; Rabinowitz MR; Rosen MR; Nyquist GG; Cohn J; Most J; Toskala EM
    Int Forum Allergy Rhinol; 2022 Mar; 12(3):306-309. PubMed ID: 34719120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.